Publications by authors named "Ayu Watanabe"

Claim this Profile
C
Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study.
Ayu Watanabe, Masahiro Kamata, Yoshiki Okada, Shoya Suzuki, Chika Chijiwa

J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform Dermatitis.
Teruo Shimizu, Masahiro Kamata, Hideya Uratsuji, Yoshiki Okada, Ayu Watanabe

J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidences of Herpes Zoster and Acne by Age in Japanese Patients With Atopic Dermatitis During Treatment With Baricitinib or Upadacitinib: A Single-Centre Retrospective Study.
Ayu Watanabe, Masahiro Kamata, Yoshiki Okada, Yayoi Tomura, Yayoi Tada

Exp Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
Shoya Suzuki, Masahiro Kamata, Hideaki Uchida, Teruo Shimizu, Yoshiki Okada, Ayu Watanabe

J Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report.
Shoya Suzuki, Masahiro Kamata, Makoto Ito, Ayu Watanabe, Hideaki Uchida

J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience of 3-Year Treatment With Dupilumab: Significant Decrease in Circulating Neutrophils and Eosinophils in Japanese Patients With Atopic Dermatitis.
Hideyuki Nakajima, Masahiro Kamata, Yoshiki Okada, Shoya Suzuki, Makoto Ito, Ayu Watanabe

Exp Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors.
Ryosuke Takeshima, Masahiro Kamata, Shoya Suzuki, Makoto Ito, Ayu Watanabe

J Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possibility of maintaining remission with topical therapy alone after withdrawal of dupilumab in Japanese patients with atopic dermatitis and their characteristics in the real world.
Ayu Watanabe, Masahiro Kamata, Yoshiki Okada, Shoya Suzuki, Makoto Ito

Exp Dermatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
Yoshiko Niimura, Masahiro Kamata, Takeko Ishikawa, Mayumi Nagata, Makoto Ito, Ayu Watanabe

J Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan.
Kenji Hiraizumi, Chikara Honda, Ayu Watanabe, Takafumi Nakao, Shuichi Midorikawa

Int J Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.
Hideyuki Nakajima, Masahiro Kamata, Yoshiki Okada, Makoto Ito, Ayu Watanabe

Eur J Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis.
Emi Sakurai, Masahiro Kamata, Hideaki Uchida, Yoshiki Okada, Shoya Suzuki, Ayu Watanabe

Exp Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of fosravuconazole for the treatment of onychomycosis in haemodialysis patients: A single-centre retrospective study.
Hideaki Uchida, Masahiro Kamata, Takeko Ishikawa, Makoto Ito, Ayu Watanabe

J Eur Acad Dermatol Venereol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of interleukin-36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene.
Itsumi Mizukawa, Masahiro Kamata, Teruo Shimizu, Makoto Ito, Ayu Watanabe

J Dermatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis.
Hideaki Uchida, Masahiro Kamata, Ayu Watanabe, Makoto Ito, Saki Fukaya

J Dermatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of angiogenesis-related factors in patients with psoriasis.
Ayu Watanabe, Masahiro Kamata, Teruo Shimizu, Hideaki Uchida, Emi Sakurai

J Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of an online application to identify potential immune-related adverse events associated with immune checkpoint inhibitors based on the patient's symptoms.
Takahiro Osawa, Takashige Abe, Hiroshi Kikuchi, Ryuji Matsumoto, Sachiyo Murai, Ayu Watanabe

PLoS One· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
Hideaki Uchida, Masahiro Kamata, Teruo Shimizu, Shota Egawa, Makoto Ito, Ayu Watanabe

J Dermatol Sci· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year real-world clinical effectiveness, safety, and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study.
Hideaki Uchida, Masahiro Kamata, Aika Kato, Itsumi Mizukawa, Ayu Watanabe

J Am Acad Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.
Hideaki Uchida, Masahiro Kamata, Ayu Watanabe, Ai Agematsu, Mayumi Nagata

Acta Derm Venereol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors.
Wataru Ichinose, Stanislav M Cherepanov, Anna A Shabalova, Shigeru Yokoyama, Teruko Yuhi, Ayu Watanabe, Mizuki Watanabe

J Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis